This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Proteomedix Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Kathrin Endt: Innovator in Protein Detection Methods
Introduction
Kathrin Endt is a notable inventor based in Germering, Germany. She has made significant contributions to the field of health diagnostics through her innovative methods for detecting proteins in human samples. Her work is particularly relevant in understanding health status through quantitative analysis.
Latest Patents
Kathrin Endt holds a patent for a method of detecting proteins in human samples. This method involves the quantitative detection of specific proteins, including THBS1 and free PSA, in serum, plasma, or blood. The patent outlines a process that can provide valuable information regarding the health status of individuals by analyzing the concentration of these proteins.
Career Highlights
Endt is associated with Proteomedix AG, a company focused on advancing diagnostic technologies. Her work at Proteomedix AG has been instrumental in developing innovative solutions for health diagnostics. With her expertise, she has contributed to the advancement of methods that enhance the accuracy of health assessments.
Collaborations
Kathrin Endt collaborates with Alcibiade Athanasiou, working together to push the boundaries of protein detection and health diagnostics. Their partnership exemplifies the importance of teamwork in driving innovation in the medical field.
Conclusion
Kathrin Endt's contributions to protein detection methods highlight her role as a key innovator in health diagnostics. Her work not only advances scientific understanding but also has the potential to improve health outcomes for individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile